Argentum 47 Inc. has announced a recent share purchase agreement under which the company has acquired 100% of the ordinary shares of Marelius Biopharma Group Ltd, previously known as Sterifox Pharma Ltd & Sterifox Pharma Academy Ltd. This acquisition is part of Argentum 47 Inc.'s strategy to enhance innovation within pharmaceutical and biopharmaceutical manufacturing processes. The agreement marks a significant expansion of Argentum 47's portfolio in the biopharma sector.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Argentum 47 Inc. published the original content used to generate this news brief on May 14, 2025, and is solely responsible for the information contained therein.